# MFA Financial, Inc.: financial statements, quarterly

MFA · NYSE · CIK 1055160 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mfa.md) · [Financials](/companies/mfa/financials.md) · [Filings](/companies/mfa/filings.md) · [Insiders](/companies/mfa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mfa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [113](/filings/0001055160-23-000020.md) | [123 d](/filings/0001055160-24-000005.md) | [129](/filings/0001055160-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001055160-24-000023.md) | [(0.0) d](/filings/0001055160-26-000004.md) | [1.0](/filings/0001055160-25-000007.md) | [0.3](/filings/0001055160-25-000013.md) | [1.5](/filings/0001055160-25-000018.md) | [(2.5) d](/filings/0001055160-26-000004.md) | [(0.9)](/filings/0001055160-26-000008.md) | [0.2](/filings/0001055160-26-000015.md) | [(0.1)](/filings/0001055160-25-000018.md) | [0.0 d](/filings/0001055160-26-000004.md) | [0.0](/filings/0001055160-26-000008.md) | [0.0](/filings/0001055160-26-000015.md) |
| Net income | $m | [(56.4)](/filings/0001055160-24-000023.md) | [89.7 d](/filings/0001055160-26-000004.md) | [23.2](/filings/0001055160-25-000018.md) | [41.9](/filings/0001055160-25-000018.md) | [48.2](/filings/0001055160-25-000018.md) | [5.9 d](/filings/0001055160-26-000004.md) | [41.2](/filings/0001055160-26-000015.md) | [33.2](/filings/0001055160-26-000015.md) | [48.1](/filings/0001055160-25-000018.md) | [54.3 d](/filings/0001055160-26-000004.md) | [(1.0)](/filings/0001055160-26-000015.md) | [46.8](/filings/0001055160-26-000015.md) |
| Diluted EPS | $ per share | [(0.64)](/filings/0001055160-24-000023.md) | not reported | [0.14](/filings/0001055160-25-000007.md) | [0.32](/filings/0001055160-25-000013.md) | [0.37](/filings/0001055160-25-000018.md) | not reported | [0.31](/filings/0001055160-26-000008.md) | [0.21](/filings/0001055160-26-000015.md) | [0.35](/filings/0001055160-25-000018.md) | not reported | [(0.11)](/filings/0001055160-26-000008.md) | [0.34](/filings/0001055160-26-000015.md) |
| Basic EPS | $ per share | [(0.64)](/filings/0001055160-24-000023.md) | not reported | [0.14](/filings/0001055160-25-000007.md) | [0.32](/filings/0001055160-25-000013.md) | [0.38](/filings/0001055160-25-000018.md) | not reported | [0.32](/filings/0001055160-26-000008.md) | [0.22](/filings/0001055160-26-000015.md) | [0.36](/filings/0001055160-25-000018.md) | not reported | [(0.11)](/filings/0001055160-26-000008.md) | [0.35](/filings/0001055160-26-000015.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001055160-23-000020.md) | [0.3](/filings/0001055160-25-000004.md) | [0.3](/filings/0001055160-24-000012.md) | [0.3](/filings/0001055160-24-000018.md) | [0.3](/filings/0001055160-24-000023.md) | [0.3](/filings/0001055160-26-000004.md) | [0.3](/filings/0001055160-25-000007.md) | [0.3](/filings/0001055160-25-000013.md) | [0.3](/filings/0001055160-25-000018.md) | [0.2](/filings/0001055160-26-000015.md) | [0.2](/filings/0001055160-26-000008.md) | [0.1](/filings/0001055160-26-000015.md) |
| Total assets | $bn | [10.1](/filings/0001055160-23-000020.md) | [10.8](/filings/0001055160-25-000004.md) | [10.9](/filings/0001055160-24-000012.md) | [11.1](/filings/0001055160-24-000018.md) | [11.2](/filings/0001055160-24-000023.md) | [11.4](/filings/0001055160-26-000004.md) | [11.5](/filings/0001055160-25-000007.md) | [11.7](/filings/0001055160-25-000013.md) | [12.1](/filings/0001055160-25-000018.md) | [13.0](/filings/0001055160-26-000015.md) | [13.2](/filings/0001055160-26-000008.md) | [13.7](/filings/0001055160-26-000015.md) |
| Total liabilities | $bn | [8.3](/filings/0001055160-23-000020.md) | [8.9](/filings/0001055160-25-000004.md) | [9.0](/filings/0001055160-24-000012.md) | [9.2](/filings/0001055160-24-000018.md) | [9.3](/filings/0001055160-24-000023.md) | [9.6](/filings/0001055160-26-000004.md) | [9.7](/filings/0001055160-25-000007.md) | [9.9](/filings/0001055160-25-000013.md) | [10.3](/filings/0001055160-25-000018.md) | [11.2](/filings/0001055160-26-000015.md) | [11.5](/filings/0001055160-26-000008.md) | [11.9](/filings/0001055160-26-000015.md) |
| Shareholders' equity | $bn | [1.8](/filings/0001055160-24-000023.md) | [1.9](/filings/0001055160-26-000004.md) | [1.9](/filings/0001055160-25-000018.md) | [1.9](/filings/0001055160-25-000018.md) | [1.9](/filings/0001055160-25-000018.md) | [1.8](/filings/0001055160-26-000015.md) | [1.8](/filings/0001055160-26-000015.md) | [1.8](/filings/0001055160-26-000015.md) | [1.8](/filings/0001055160-25-000018.md) | [1.8](/filings/0001055160-26-000015.md) | [1.8](/filings/0001055160-26-000015.md) | [1.8](/filings/0001055160-26-000015.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.8 d](/filings/0001055160-24-000023.md) | [3.8 d](/filings/0001055160-26-000004.md) | [53.5](/filings/0001055160-25-000007.md) | [46.5 d](/filings/0001055160-25-000013.md) | [(11.3) d](/filings/0001055160-25-000018.md) | [111 d](/filings/0001055160-26-000004.md) | [(14.6)](/filings/0001055160-26-000008.md) | [38.5 d](/filings/0001055160-26-000015.md) | [14.7 d](/filings/0001055160-25-000018.md) | [37.6 d](/filings/0001055160-26-000004.md) | [71.1](/filings/0001055160-26-000008.md) | [129 d](/filings/0001055160-26-000015.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [35.8 d](/filings/0001055160-24-000023.md) | [35.8 d](/filings/0001055160-26-000004.md) | [35.8](/filings/0001055160-25-000007.md) | [36.0 d](/filings/0001055160-25-000013.md) | [36.0 d](/filings/0001055160-25-000018.md) | [36.0 d](/filings/0001055160-26-000004.md) | [35.9](/filings/0001055160-26-000008.md) | [37.4 d](/filings/0001055160-26-000015.md) | [37.6 d](/filings/0001055160-25-000018.md) | [37.3 d](/filings/0001055160-26-000004.md) | [38.9](/filings/0001055160-26-000008.md) | [37.7 d](/filings/0001055160-26-000015.md) |
| Share repurchases | $m | [0.0 d](/filings/0001055160-24-000023.md) | [0.0 d](/filings/0001055160-26-000004.md) | [1.5](/filings/0001055160-25-000007.md) | [0.0 d](/filings/0001055160-25-000013.md) | [0.0 d](/filings/0001055160-25-000018.md) | [0.0 d](/filings/0001055160-26-000004.md) | [5.2](/filings/0001055160-26-000008.md) | [0.0 d](/filings/0001055160-26-000015.md) | [5.1 d](/filings/0001055160-25-000018.md) | [5.0 d](/filings/0001055160-26-000004.md) | [9.0](/filings/0001055160-26-000008.md) | [5.1 d](/filings/0001055160-26-000015.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [102](/filings/0001055160-23-000020.md) | [110](/filings/0001055160-24-000012.md) | [102](/filings/0001055160-24-000018.md) | [102](/filings/0001055160-24-000023.md) | [105](/filings/0001055160-25-000007.md) | [105](/filings/0001055160-25-000013.md) | [106](/filings/0001055160-25-000018.md) | [105](/filings/0001055160-26-000008.md) | [105](/filings/0001055160-26-000015.md) | [106](/filings/0001055160-25-000018.md) | [106](/filings/0001055160-26-000008.md) | [105](/filings/0001055160-26-000015.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 101,087,938 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001055160-26-000015.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.